A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Kaoru TanakaSatoshi MoritaMasahiko AndoTakuma YokoyamaAtsushi NakamuraHiroshige YoshiokaTakashi IshiguroSatoru MiuraRyo ToyozawaTetsuya OguriHaruko DagaRyo KoAkihiro BesshoMotoko TachiharaYasuo IwamotoKatsuya HiranoYoichi NakanishiKazuhiko NakagawaNobuyuki YamamotoIsamu OkamotoPublished in: Cancer (2020)
Continued maintenance with S-1 plus BSC is an effective and well-tolerated treatment option for patients with advanced squamous NSCLC previously treated with carboplatin plus S-1.
Keyphrases
- squamous cell carcinoma
- healthcare
- palliative care
- small cell lung cancer
- phase ii study
- quality improvement
- acute lymphoblastic leukemia
- acute myeloid leukemia
- diffuse large b cell lymphoma
- multiple myeloma
- affordable care act
- randomized controlled trial
- hodgkin lymphoma
- lymph node metastasis
- locally advanced
- bone marrow
- cell therapy